SKShima Kalantarifard

Shima Kalantarifard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shima Kalantarifard has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cyclodextrin-epichlorohydrin-cyanoguanidine polymer for resveratrol delivery to enhance human chondrocyte function in cartilage repair

    by Mahmoud A. Elmeligy, Forough Rasoulian, Shima Kalantarifard, Juraj Filo, Sahar Dinparvar, Ahmed M. Omer, Lucy Vojtová, Stefan Nehrer, Igor Lacík, Abolfazl Heydari

    Water-soluble β-cyclodextrin-epichlorohydrin polymers (CDP) are widely utilized for molecular encapsulation, drug delivery, and regenerative medicine. In this work, we present the synthesis of a novel polymer of this family, β-cyclodextrin-epichlorohydrin-cyanoguanidine polymer (CDPC). The primary objective was to evaluate its potential as an efficient carrier for the encapsulation of resveratrol (RES), with a particular focus on applications in cartilage repair. CDPC was synthesized by reacting β-cyclodextrin (β-CD) with epichlorohydrin in the presence of cyanoguanidine (CyG), a nitrogen-rich compound that remains non-protonated under physiological pH. The incorporation of CyG into the polymer network was tuned by adjusting CyG to β-CD molar ratio. Structural characterization of the CDPC was performed using a combination of analytical techniques, including 1H NMR, 13C NMR, HSQC, DOSY NMR, FT-IR, and CHN elemental analysis. Compared to CDP, CDPC exhibited improved RES encapsulation efficiency, as demonstrated by phase solubility and encapsulation studies. The enhanced encapsulation is attributed to additional intramolecular interactions provided by CyG moieties. Dynamic light scattering revealed nanoscale polymer-RES complexes with average sizes of 4 nm for CDP/RES and 18 nm for CDPC/RES, while zeta potential values indicated that these complexes are neutral to slightly negatively charged. CDPC demonstrated intrinsic antioxidant activity, further enhanced upon RES encapsulation. Cytocompatibility assays confirmed that both CDP and CDPC were non-toxic to human chondrocytes. Confocal microscopy of FITC-labeled CDP and CDPC demonstrated effective internalization of these polymers by chondrocytes. Moreover, the CDP/RES and CDPC/RES complexes enhanced chondrocyte metabolic activity and extracellular matrix deposition, demonstrating their potential as carriers for drug delivery in cartilage tissue regeneration.